Correlation Between Medigen Vaccine and Chunghwa Chemical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medigen Vaccine and Chunghwa Chemical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Vaccine and Chunghwa Chemical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medigen Vaccine Biologics and Chunghwa Chemical Synthesis, you can compare the effects of market volatilities on Medigen Vaccine and Chunghwa Chemical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Vaccine with a short position of Chunghwa Chemical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Vaccine and Chunghwa Chemical.

Diversification Opportunities for Medigen Vaccine and Chunghwa Chemical

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between Medigen and Chunghwa is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Vaccine Biologics and Chunghwa Chemical Synthesis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chunghwa Chemical and Medigen Vaccine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Vaccine Biologics are associated (or correlated) with Chunghwa Chemical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chunghwa Chemical has no effect on the direction of Medigen Vaccine i.e., Medigen Vaccine and Chunghwa Chemical go up and down completely randomly.

Pair Corralation between Medigen Vaccine and Chunghwa Chemical

Assuming the 90 days trading horizon Medigen Vaccine Biologics is expected to generate 2.57 times more return on investment than Chunghwa Chemical. However, Medigen Vaccine is 2.57 times more volatile than Chunghwa Chemical Synthesis. It trades about 0.34 of its potential returns per unit of risk. Chunghwa Chemical Synthesis is currently generating about 0.03 per unit of risk. If you would invest  3,705  in Medigen Vaccine Biologics on October 24, 2024 and sell it today you would earn a total of  1,265  from holding Medigen Vaccine Biologics or generate 34.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Medigen Vaccine Biologics  vs.  Chunghwa Chemical Synthesis

 Performance 
       Timeline  
Medigen Vaccine Biologics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Medigen Vaccine Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Medigen Vaccine showed solid returns over the last few months and may actually be approaching a breakup point.
Chunghwa Chemical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chunghwa Chemical Synthesis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Medigen Vaccine and Chunghwa Chemical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medigen Vaccine and Chunghwa Chemical

The main advantage of trading using opposite Medigen Vaccine and Chunghwa Chemical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Vaccine position performs unexpectedly, Chunghwa Chemical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chunghwa Chemical will offset losses from the drop in Chunghwa Chemical's long position.
The idea behind Medigen Vaccine Biologics and Chunghwa Chemical Synthesis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
CEOs Directory
Screen CEOs from public companies around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume